Sfoglia per AUTORE
ARENA V
Collezione ASL Asti

  

Items : 2

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Cuneo A; Foà R; Marchetti M; Gentile M; Vignetti M; Mauro FR; Crea E; Marasca R; Laurenti L; Molinari AL; Pietrasanta D; Quaglia FM; Sportoletti P; Paolini R; Varettoni M; Gaidano G; Murru R; Vitagliano O; Coscia M; Farina L; Cibien F; Zamprogna G; Arena V; Visentin A; Reda G; Cavazzini F; Piciocchi A; Montillo M; Rigolin GM; et alii...

Complex Karyotype Is Associated with A Less Favorable Outcome after Ibrutinib and Rituximab As Front-Line Treatment of Unfit Patients with Chronic Lymphocytic Leukemia (GIMEMA LLC1114) in Haematologica

2020
ASL Asti

Del Giudice I; Rigolin GM; Bardi A; Melandri A; Cavallari M; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Fabri S; Albano F; Nanni M; Molica S; Reda G; Sportoletti M; Trentin L; Marchetti M; Peragine N; Mariglia P; Vignetti M; Mauro FR; Guarini A; Foà R; Cuneo A;